Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP

Abstract

YAP (Yes-associated protein) oncogene has been found to form a stable complex with members of the Angiomotin (Amot) family of proteins, which bind WW domains of YAP and sequester the protein in the cytoplasm and junctional complexes. The Amot-mediated retention of YAP in the cytoplasm results in the inhibition of its proliferative function. Using apoptotic ‘read-out’ of YAP in HEK293 cells, we confirmed the molecular mode by which Amot regulates YAP. We showed that a representative member of the Amot family, AmotL1 (Angiomotin-like-1), uses its PPxY motifs to bind WW domains of YAP and inhibit YAP's nuclear translocation and pro-apoptotic function. Recently we also showed that YAP uses its PDZ-binding motif to interact with zona occludens-2 (ZO-2) protein, which promotes YAP's translocation to the nucleus. We also asked if AmotL1, YAP and ZO-2 signal together. We report here that AmotL1 and ZO-2 form a tripartite complex with YAP and regulate its function in HEK293 cells in opposite directions. AmotL1 inhibits pro-apoptotic function of YAP, whereas ZO-2 enhances it. As YAP is a potent oncogene, the identification and characterization of its regulators is important. AmotL1 and ZO-2 are two candidates that could be harnessed to control the oncogenic function of YAP.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Basu S, Totty NF, Irwin MS, Sudol M, Downward J . (2003). Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 11: 11–23.

    Article  CAS  Google Scholar 

  • Bratt A, Birot O, Sinha I, Veitonmaki N, Aase K, Ernkvist M et al. (2005). Angiomotin regulates endothelial cell-cell junctions and cell motility. J Biol Chem 280: 34859–34869.

    Article  CAS  Google Scholar 

  • Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, Van Meir EG et al. (2002). Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene 298: 69–77.

    Article  CAS  Google Scholar 

  • Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W . (2011). Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 286: 7018–7026.

    Article  CAS  Google Scholar 

  • Ehsanian R, Brown M, Lu H, Yang XP, Pattatheyil A, Yan B et al. (2010). YAP dysregulation by phosphorylation or DeltaNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets. Oncogene 29: 6160–6171.

    Article  CAS  Google Scholar 

  • Matallanas D, Romano D, Yee K, Meissl K, Kucerova L, Piazzolla D et al. (2007). RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 27: 962–975.

    Article  CAS  Google Scholar 

  • Matsuda T, Cepko CL . (2007). Controlled expression of transgenes introduced by in vivo electroporation. Proc Natl Acad Sci USA 104: 1027–1032.

    Article  CAS  Google Scholar 

  • Nishimura M, Kakizaki M, Ono Y, Morimoto K, Takeuchi M, Inoue Y et al. (2002). JEAP, a novel component of tight junctions in exocrine cells. J Biol Chem 277: 5583–5587.

    Article  CAS  Google Scholar 

  • Oka T, Mazack V, Sudol M . (2008). Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J Biol Chem 283: 27534–27546.

    Article  CAS  Google Scholar 

  • Oka T, Remue E, Meerschaert K, Vanloo B, Boucherie C, Gfeller D et al. (2010). Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling. Biochem J 432: 461–472.

    Article  CAS  Google Scholar 

  • Oka T, Sudol M . (2009). Nuclear localization and pro-apoptotic signaling of YAP2 require intact PDZ-binding motif. Genes Cells 14: 607–615.

    Article  CAS  Google Scholar 

  • Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC et al. (2006). Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A 103: 12405–12410.

    Article  CAS  Google Scholar 

  • Pan D . (2010). The hippo signaling pathway in development and cancer. Dev Cell 19: 491–505.

    Article  CAS  Google Scholar 

  • Pei Z, Bai Y, Schmitt AP . (2010). PIV5M protein interaction with host protein angiomotin-like 1. Virology 397: 155–166.

    Article  CAS  Google Scholar 

  • Sowa ME, Bennett EJ, Gygi SP, Harper JW . (2009). Defining the human deubiquitinating enzyme interaction landscape. Cell 138: 389–403.

    Article  CAS  Google Scholar 

  • Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A et al. (2001). Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem 276: 15164–15173.

    Article  CAS  Google Scholar 

  • Sudol M, Harvey KF . (2010). Modularity in the Hippo signaling pathway. Trends Biochem Sci 35: 627–633.

    Article  CAS  Google Scholar 

  • Sudol M . (2010). Newcomers to the WW domain-mediated network of the Hippo tumor suppressor pathway. Genes Cancer 1: 1115–1118.

    Article  CAS  Google Scholar 

  • Sugihara-Mizuno Y, Adachi M, Kobayashi Y, Hamazaki Y, Nishimura M, Imai T et al. (2007). Molecular characterization of angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their endogenous properties. Genes Cells 12: 473–486.

    Article  CAS  Google Scholar 

  • Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L . (2001). Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 152: 1247–1254.

    Article  CAS  Google Scholar 

  • Wang W, Huang J, Chen J . (2011). Angiomotin-like Proteins Associate with and Negatively Regulate YAP1. J Biol Chem 286: 4364–4370.

    Article  CAS  Google Scholar 

  • Yuan M, Tomlinson V, Lara R, Holliday D, Chelala C, Hanada T et al. (2008). Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 15: 1752–1759.

    Article  CAS  Google Scholar 

  • Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q et al. (2011). Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25: 51–63.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Dr Makoto Adachi from Kyoto University in Japan for a kind gift of HA-tagged mouse Amot family plasmids and Priya Raghavan for experiments, which confirmed our initial observations. We also acknowledge members of the Sudol laboratory for helpful comments on the manuscript.

This research was supported by PA Breast Cancer Coalition grants (#60707 and #9200903) and by Geisinger Clinic.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Sudol.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oka, T., Schmitt, A. & Sudol, M. Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. Oncogene 31, 128–134 (2012). https://doi.org/10.1038/onc.2011.216

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2011.216

Keywords

This article is cited by

Search

Quick links